Pancreatic Cancer Research

ResearcherXijing HospitalNo recent work listed

Hongmei Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3991-3750; OpenAlex author ID A5100320777. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2022: 2 papers · 2023: 1 paper

Papers 3

  1. Nimotuzumab Plus Gemcitabine for K-Ras Wild-Type Locally Advanced or Metastatic Pancreatic Cancer. Co-author DOI 10.1200/jco.22.02630↗
  2. Identification of stromal microenvironment characteristics and key molecular mining in pancreatic cancer. Last author DOI 10.1007/s12672-022-00532-y↗
  3. Identification of stromal microenvironment characteristics and key molecular mining in pancreatic cancer Last author DOI 10.21203/rs.3.rs-1632849/v2↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hongchen Ji · 2 shared papers, 2022 · strength 0.31
  2. Junjie Li · 2 shared papers, 2022 · strength 0.31
  3. Chunyi Hao · 1 shared paper, 2023 · strength 0.13
  4. Tianshu Liu · 1 shared paper, 2023 · strength 0.13
  5. Ying Yuan · 1 shared paper, 2023 · strength 0.13
  6. Lin Yang · 1 shared paper, 2023 · strength 0.13
  7. Lin Shen · 1 shared paper, 2023 · strength 0.13
  8. Jianming Xu · 1 shared paper, 2023 · strength 0.13
  9. Rui‐Hua Xu · 1 shared paper, 2023 · strength 0.13
  10. Qingshan Zheng · 1 shared paper, 2023 · strength 0.13
  11. Jin Li · 1 shared paper, 2023 · strength 0.13
  12. Jun Zhang Zhang · 1 shared paper, 2023 · strength 0.13
  13. Shukui Qin · 1 shared paper, 2023 · strength 0.13
  14. Deliang Fu · 1 shared paper, 2023 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.